Tag Archives: Antiretroviral drug

On intellectual property rights and antiretroviral drugs

The Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS), originally signed in 1994, gave developing countries until 2005 to bring their IP laws in line with the new legislation. With respect to drugs, Indian, Brazilian, and Thai pharmaceutical firms could no longer copy drugs that American and European firms had created. Before 2005, however,… Read More »